IVPost
Study explains why opioid therapy may not always work well for chronic pain
- Details
- Written by National Center for Complementary and Integrative Health
- Category: Health News
Researchers have shown that pain-induced changes in the rat brain’s opioid receptor system may explain the limited effectiveness of opioid therapy in chronic pain and may play a role in the depression that often accompanies it. These findings clearly show the impact of chronic pain on the brain and its relation to depression. The study, conducted by scientists at the National Institutes of Health (NIH) and colleagues from McGill University, Montreal, Quebec, Canada, was published in the journal Pain.
NIH begins testing Ebola treatment in early-stage trial
- Details
- Written by Jennifer Routh
- Category: Latest News
A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland. The Phase 1 clinical trial is examining the safety and tolerability of a single monoclonal antibody called mAb114, which was developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, and their collaborators. Investigators aim to enroll between 18 and 30 healthy volunteers aged 18 to 60. The trial will not expose participants to Ebola virus.
Michigan Home Health Agency Owner Pleads Guilty to Health Care Fraud Charges for Role in $8 Million Medicare Fraud Scheme
- Details
- Written by DOJ
- Category: Health Care Fraud
The owner of a Michigan home health agency pleaded guilty today to fraud charges for his role in a scheme involving approximately $8 million in fraudulent Medicare claims for home health services that were procured through the payment of illegal kickbacks.
United States Intervenes in False Claims Act Lawsuits Accusing Insys Therapeutics of Paying Kickbacks and Engaging in Other Unlawful Practices to Promote Subsys, A Powerful Opioid Painkiller
- Details
- Written by IVP
- Category: Latest News
On April 13, 2018, the United States intervened in five lawsuits accusing Insys Therapeutics Inc., of violating the False Claims Act in connection with the marketing of Subsys, an opioid painkiller manufactured and sold by Insys, the Department of Justice announced today. Subsys is a sublingual spray form of fentanyl, a powerful, but highly addictive, opioid painkiller. In 2012, Subsys was approved by the Food and Drug Administration for the treatment of persistent breakthrough pain in adult cancer patients who are already receiving, and tolerant to, around-the-clock opioid therapy.
South Texas Doctor Charged with $240 Million Health Care Fraud and International Money Laundering Scheme
- Details
- Written by DOJ
- Category: Health Care Fraud
A physician based in the McAllen, Texas area was charged in an indictment unsealed today for his role in a $240 million health care fraud and international money laundering scheme.
Jackie L. Boucher, MS, RDN, to Receive the American Diabetes Association’s 2018 Outstanding Educator in Diabetes Award
- Details
- Written by IVPost
- Category: Health News
Jackie L. Boucher, MS, RDN, is the recipient of the American Diabetes Association’s® (ADA’s) 2018 Outstanding Educator in Diabetes award. This award recognizes a distinguished health professional who has made outstanding educational efforts in the field of diabetes and has demonstrated significant contributions to the understanding of diabetes education.
Page 7 of 50